United States (US) Cholera Vaccines Market (2025-2031) | Value, Competitive Landscape, Forecast, Analysis, Size & Revenue, Segmentation, Growth, Companies, Outlook, Share, Trends, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cholera Vaccines Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cholera Vaccines Market - Industry Life Cycle

3.4 United States (US) Cholera Vaccines Market - Porter's Five Forces

3.5 United States (US) Cholera Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F

3.6 United States (US) Cholera Vaccines Market Revenues & Volume Share, By Product, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cholera outbreaks in certain regions of the United States

4.2.2 Rising awareness about the importance of vaccination in preventing infectious diseases

4.2.3 Government initiatives and campaigns promoting vaccination against cholera

4.3 Market Restraints

4.3.1 Limited public health infrastructure in some areas leading to challenges in vaccine distribution and administration

4.3.2 High cost associated with cholera vaccines leading to affordability issues for certain population segments

4.3.3 Vaccine hesitancy and misinformation about the safety and efficacy of cholera vaccines

6.1 United States (US) Cholera Vaccines Market, By Vaccine Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Cholera Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F

6.1.3 United States (US) Cholera Vaccines Market Revenues & Volume, By Whole cell V. cholerae O1 with Recombinant B-subunit, 2021- 2031F

6.1.4 United States (US) Cholera Vaccines Market Revenues & Volume, By Killed Oral O1 and O139, 2021- 2031F

6.2 United States (US) Cholera Vaccines Market, By Product

6.2.1 Overview and Analysis

6.2.2 United States (US) Cholera Vaccines Market Revenues & Volume, By Vaxchora, 2021- 2031F

6.2.3 United States (US) Cholera Vaccines Market Revenues & Volume, By Dukoral, 2021- 2031F

6.2.4 United States (US) Cholera Vaccines Market Revenues & Volume, By Shanchol, 2021- 2031F

6.2.5 United States (US) Cholera Vaccines Market Revenues & Volume, By Other Products, 2021- 2031F

7.1 United States (US) Cholera Vaccines Market Export to Major Countries

7.2 United States (US) Cholera Vaccines Market Imports from Major Countries

8.1 Vaccination coverage rates in high-risk areas

8.2 Number of government-funded vaccination programs for cholera prevention

8.3 Public perception and acceptance of cholera vaccination as a preventive measure

8.4 Number of reported cholera cases in regions with high vaccination coverage

8.5 Research and development investments in improving cholera vaccine technology and accessibility

9.1 United States (US) Cholera Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F

9.2 United States (US) Cholera Vaccines Market Opportunity Assessment, By Product, 2021 & 2031F

10.1 United States (US) Cholera Vaccines Market Revenue Share, By Companies, 2024

10.2 United States (US) Cholera Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters